Mohammad Taher
1,2 
, Arash Miroliaee
2, Nasser Ebrahimi Daryani
2, Foroogh Alborzi Avanaki
2, Najmeh Aletaha
2, Mohsen Nasiri-Toosi
1,2, Habibollah Dashti
1,3, Vahid Basirat
2, Ali Jafarian
1,3* 1 Liver transplantation Center, Tehran University of Medical Sciences, Tehran, Iran
2 Division of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Imam Khomeini Hospital Complex, Tehran, Iran
3 Division of Hepatopancreatobiliary and Liver Transplantation Surgery, Imam Khomeini Hospital Complex, Tehran, Iran
*Corresponding Author: *Corresponding Author: Ali Jafarian, MD; Keshavarz Bulv., Imam Khomeini Hospital Complex, Liver Transplantation Research Center, Tehran, Iran. Tel: +98-21-66581657; Fax: +98-21-66581657; Email: , Email:
jafarian@tums.ac.ir
Abstract
The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.